GlobalRPh Renal Dosing Masterv6.6
GlobalRPh source record

Amoxicillin

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Cautions / source differences (2)
Review first - source-specific qualification

Before use: Amoxicillin

Galway uses indexed eGFR and inpatient IV/PO ranges, whereas UCSF provides indication-specific oral CrCl schedules and specified dialysis assumptions. The printed UCSF headings leave exactly 30 unassigned. These protocols are not interchangeable.

Before applying: Resolve the printed boundary and match the indication, oral route and actual dialysis prescription.

Evidence for this qualification

Source-specific interpretation; independent clinician adjudication pending.

Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.

Choose a source to read (5)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

1 additional source qualifications - review before use
Age and weight remain part of the renal table

The renal heading covers adults and children aged at least 3 months weighing more than 40 kg; it is not a small-child or neonatal schedule. The source also specifies additional doses both during and at the end of hemodialysis.

Before applying: Confirm population and local dialysis protocol. Do not silently change the source schedule.

Also check: Age and weight remain part of the renal table

Professional source

Galway GAPP - amoxicillin IV/PO

Product / population
Hospitalized adults; Irish institutional guidance, not a US product label.
Renal measure
Indexed eGFR, mL/min/1.73 m2; source identifies exceptions requiring Cockcroft-Gault.
Before using this finding

Keep route, indication, renal measure and dialysis modality together; do not merge the Galway and UCSF regimens.

Renal guidance and important limits

Limits that apply to these rows

The asterisk marks significant differences among references. Usual dosing means the local normal-renal/hepatic regimen.

CRRT is outside this guideline. Route, severity and renal measure must remain attached; do not combine its interval with another source dose.

Galway amoxicillin IV/PO - hospitalized adults
Indexed eGFR (mL/min/1.73 m2)Source-specific instruction
10-50No renal dose adjustment in this institutional table
<10250 mg to 1 g every 8 hours
<10, high-dose endocarditis or Listeria meningitisMaximum 2 g every 8 hours
Read the retained text before reformatting

Galway amoxicillin IV/PO - hospitalized adults

Indexed eGFR (mL/min/1.73 m2)Source-specific instruction
10-50No renal dose adjustment in this institutional table
<10250 mg to 1 g every 8 hours
<10, high-dose endocarditis or Listeria meningitisMaximum 2 g every 8 hours

The asterisk marks significant differences among references. Usual dosing means the local normal-renal/hepatic regimen.

CRRT is outside this guideline. Route, severity and renal measure must remain attached; do not combine its interval with another source dose.

Source revision: Revision not established in selected retrieval | Retrieved: 2026-09-10. Retrieval date is not the revision date.

Source: https://eguides.megsupporttools.com/public/guh/renal-dosing-adults/?view=menu

Scope: Selected source sections stored locally. Not a complete monograph or independent clinical approval. GlobalRPh v6.6.

Full source card / provenance

All sources, comparison tools and evidence navigation
Source-specific interpretation

What the dialysis evidence actually supports

Removal information alone does not define a maintenance dose, supplemental dose or dialysis schedule. A reported regimen still requires its product, indication, renal measure and dialysis assumptions to match the patient.

GlobalRPh RX List - AMOXIL

Authored v6.1; retrieved 2026-09-10 - retained source, not freshly reviewed in this release

A regimen is reported in selected content

Read the source and its limits

These manual classifications apply only to the identified selected sections, not every retained source or the entire prescribing information. They are not dosing clearance.

Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Read 2 source difference / applicability notes

Preserved GlobalRPh source

Preserved original GlobalRPh source

Preserved historical content; not revalidated as current prescribing guidance.

Renal method: Read the measure and population stated in the original source sections.
Retrieved: 2026-09-05

GlobalRPh RX List

GlobalRPh RX List - AMOXIL

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Before using this finding

Confirm the adult context and the unusual during-plus-end dialysis wording; do not silently substitute a different institutional schedule.

Dialysis evidence: A regimen is reported in selected content

AMOXIL oral capsules/tablets/suspension; selected severe-renal paragraph. Not a small-child or neonatal renal dosing table.

Renal method: GFR (mL/min) as printed; no equation specified in the selected paragraph
Retrieved: 2026-09-10

Professional guidance

UCSF - amoxicillin

Adults; oral amoxicillin only, not amoxicillin/clavulanate.

Renal method: CrCl in mL/min where specified; no equation inferred.
Retrieved: 2026-09-05

Professional guidance

Galway GAPP - amoxicillin IV/PO

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Before using this finding

Keep route, indication, renal measure and dialysis modality together; do not merge the Galway and UCSF regimens.

Hospitalized adults; Irish institutional guidance, not a US product label.

Renal method: Indexed eGFR, mL/min/1.73 m2; source identifies exceptions requiring Cockcroft-Gault.
Retrieved: 2026-09-10

Professional guidance

UCSF - amoxicillin oral renal and dialysis tables

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Before using this finding

Resolve the printed boundary and match the indication, oral route and actual dialysis prescription.

Adults; oral dosing for selected indications.

Renal method: CrCl, mL/min; dialysis assumptions stated separately.
Retrieved: 2026-09-10

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Product / population check

Confirm the exact formulation before using a renal source

These links compare product identities, not interchangeable doses. A selected summary is not a complete prescribing monograph.

Source-specific review points

Read the attributed comparison notes and source cards below. No conflict has been silently adjudicated.

Source-quality holds
Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. Searches stay on this page and are not saved or sent.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources

Select two distinct source versions. The complete stored summaries will appear below.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Read before choosing a regimen

Source differences and product cautions

Search differences across all drugs

These are specific issues found during source review, not an automated judgment that one source is universally correct. A label mirror and its original label are not independent evidence.

source scope and renal guidance

Age and weight remain part of the renal table

The renal heading covers adults and children aged at least 3 months weighing more than 40 kg; it is not a small-child or neonatal schedule. The source also specifies additional doses both during and at the end of hemodialysis.

How to use this: Confirm population and local dialysis protocol. Do not silently change the source schedule.

Source-specific interpretation; independent clinician adjudication pending.

source scope and renal guidance

Before use: Amoxicillin

Galway uses indexed eGFR and inpatient IV/PO ranges, whereas UCSF provides indication-specific oral CrCl schedules and specified dialysis assumptions. The printed UCSF headings leave exactly 30 unassigned. These protocols are not interchangeable.

How to use this: Resolve the printed boundary and match the indication, oral route and actual dialysis prescription.

Source-specific interpretation; independent clinician adjudication pending.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

New source summary - independent clinical review pending. Summaries of the identified label sections are included locally. Source import and numeric transcription checks are not independent two-reference validation. Do not treat this card as an approved institutional dosing protocol.

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Choose two source checkboxes below.
Historical source content is not a current prescription. Original GlobalRPh recommendations are preserved, not automatically certified as current. Product-label and professional additions below are separately attributed. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.
Locally stored source content

Original GlobalRPh protocol

Clinical facts and comments transcribed into a structured reading format. This is not a byte-for-byte HTML archive. Original source: https://globalrph.com/renal/amoxicillin/

Usual Dosing - Adults and Pediatric Patients >3 Months

Dosing for infections caused by less susceptible organisms should follow the recommendations for severe infections.

The children's dosage is intended for individuals whose weight is less than 40 kg. Children weighing 40 kg or more should be dosed according to the adult recommendations.

Table columns could not be paired safely. Read the preserved source wording and verify the original table before use.

Infection | Severity | Usual adult dose | Usual dose for children >3 months

Ear/Nose/Throat | Mild/Moderate | 500 mg every 12 hours or 250 mg every 8 hours | 25 mg/kg/day divided every 12 hours or 20 mg/kg/day divided every 8 hours

Ear/Nose/Throat | Severe | 875 mg every 12 hours or 500 mg every 8 hours | 45 mg/kg/day divided every 12 hours or 40 mg/kg/day divided every 8 hours

Lower Respiratory Tract | Mild/Moderate or Severe | 875 mg every 12 hours or 500 mg every 8 hours | 45 mg/kg/day divided every 12 hours or 40 mg/kg/day divided every 8 hours

Skin/Skin Structure | Mild/Moderate | 500 mg every 12 hours or 250 mg every 8 hours | 25 mg/kg/day divided every 12 hours or 20 mg/kg/day divided every 8 hours

Skin/Skin Structure | Severe | 875 mg every 12 hours or 500 mg every 8 hours | 45 mg/kg/day divided every 12 hours or 40 mg/kg/day divided every 8 hours

Genitourinary Tract | Mild/Moderate | 500 mg every 12 hours or 250 mg every 8 hours | 25 mg/kg/day divided every 12 hours or 20 mg/kg/day divided every 8 hours

Genitourinary Tract | Severe | 875 mg every 12 hours or 500 mg every 8 hours | 45 mg/kg/day divided every 12 hours or 40 mg/kg/day divided every 8 hours

Gonorrhea, acute uncomplicated ano-genital and urethral infections in males and females | Adult: 3 grams as single oral dose | Prepubertal children: 50 mg/kg amoxicillin combined with 25 mg/kg probenecid as a single dose.

NOTE: SINCE PROBENECID IS CONTRAINDICATED IN CHILDREN UNDER 2 YEARS, DO NOT USE THIS REGIMEN IN THESE CASES.

All patients with gonorrhea should be evaluated for syphilis. Larger doses may be required for stubborn or severe infections.

GRPH-amoxicillin-01 · Source section: Usual Dosing - Adults and Pediatric Patients >3 MonthsRenal section finder

Renal Dosing

PO:

[CRCL >30]: No change.

[10-29 ml/min]: q8-12h. Do not use 875 mg tablet.

[<10 ml/min]: q24h. Do not use 875mg tablet.

GRPH-amoxicillin-02 · Source section: Renal DosingRenal section finder

Hemodialysis

250 to 500mg q24h plus additional dose after dialysis.

GRPH-amoxicillin-03 · Source section: HemodialysisRenal section finder
Locally imported selected renal sections

GlobalRPh RX List renal information

Rxlist

GlobalRPh RX List - AMOXIL

Open original reference

Open / share this exact local source

GlobalRPh-hosted RX List · AMOXIL oral capsules/tablets/suspension; selected severe-renal paragraph. Not a small-child or neonatal renal dosing table.

Renal method: GFR (mL/min) as printed; no equation specified in the selected paragraph
Source date: Revision not established in selected retrieval
Retrieved: 2026-09-10

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Before using this finding

Confirm the adult context and the unusual during-plus-end dialysis wording; do not silently substitute a different institutional schedule.

Dialysis evidence: A regimen is reported in selected content

Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Renal guidance and important limits

The selected adult/severe-renal paragraph uses GFR in mL/min. Do not use the 875 mg strength below 30.

GFR / treatmentSelected source regimen
10-30 mL/min250 or 500 mg every 12 hours, selected by infection severity
Below 10 mL/min250 or 500 mg every 24 hours, selected by infection severity
Hemodialysis250 or 500 mg every 24 hours, with an additional dose both during and at the end of dialysis

The renal heading covers adults and pediatric patients aged at least 3 months weighing more than 40 kg. It is not a neonatal or small-child renal table. The under-12-week section supplies no renal-impairment recommendation. Confirm age, weight, indication and formulation.

RDM61-rxlist-amoxicillin-40a112ae58-C1 · Source locator: Dosage and Administration: renal impairment; named precautions

Source-specific limits

No new official-label card was obtained for this product in v6.1. Earlier source layers, if present, were retained but not rechecked.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/amoxicillin-drug/
Retrieved
2026-09-10
Renal-function method
GFR (mL/min) as printed; no equation specified in the selected paragraph
Source date/version
Revision not established in selected retrieval
Hash meaning
Local authored summary, not source HTML/XML/PDF bytes
Local summary SHA-256
f2bf2e63bea393505d819569cc9ea1f31515d6207dffae43d35b8b3267d52079
Separate professional-source layer

University and professional protocols

Professional

UCSF - amoxicillin

Open original reference

Open / share this exact local source

UCSF Infectious Diseases Management Program · Adults; oral amoxicillin only, not amoxicillin/clavulanate.

Renal method: CrCl in mL/min where specified; no equation inferred.
Source date: Revision date not stated in the reviewed page.
Retrieved: 2026-09-05

Locally included source-specific summary. Regimen differences are not automatically resolved.

Dosing / renal protocol and limits

Limits that apply to these rows

Exactly 30 is not assigned by the printed columns. Continuous-HD guidance rests on limited evidence and local expert judgment.

Symptomatic enterococcal UTI - oral
CrCl, mL/minSource-specific dose / instruction
>30500 mg every 8 hours
10-29500 mg every 12 hours
<10500 mg every 24 hours
Selected severe infections, Gram-negative bacteremia or outpatient CAP - oral
CrCl, mL/minSource-specific dose / instruction
>301 g every 8 hours
10-291 g every 12 hours
<10500 mg every 12 hours
Dialysis guidance - separate source-specific schedules
Amoxicillin - dialysis
Dialysis setting / indicationSource-specific schedule
IHD - enterococcal UTI500 mg initially, then each evening
IHD - selected severe-infection regimen500 mg every 12 hours
CVVHD - enterococcal UTI500 mg every 8 hours
CVVHD - selected severe-infection regimen1 g every 8 hours
Read the retained text before reformatting

Oral doses for CrCl >30 / 10-29 / <10 mL/min:

  • Symptomatic enterococcal UTI: 500 mg every 8 / 12 / 24 hours.
  • Selected severe infections, Gram-negative bacteremia or outpatient community-acquired pneumonia: 1 g every 8 hours / 1 g every 12 hours / 500 mg every 12 hours.

IHD: enterococcal UTI uses 500 mg initially, then every evening; the severe-infection regimen uses 500 mg every 12 hours. CVVHD: respectively 500 mg or 1 g every 8 hours. Continuous-HD recommendations rely on limited evidence and local expert judgment.

The displayed non-dialysis bands omit exactly 30; consult an adjudicated product-specific boundary rather than inferring it.

RDM30-010-amoxicillin-1 · Source locator: UCSF - amoxicillin; renal/dosing sections and stated qualifiers

Source identity and provenance
Source
https://idmp.ucsf.edu/content/amoxicillin
Retrieved
2026-09-05
Renal-function method
CrCl in mL/min where specified; no equation inferred.
Source date/version
Revision date not stated in the reviewed page.
Hash meaning
Locally authored summary text; not original SPL, HTML or PDF bytes
Local summary SHA-256
6b6b697cbb81330f72392673fc460dd0b3d6dd29af51dd1bdb60c8fe3874f420
Professional

Galway GAPP - amoxicillin IV/PO

Open original reference

Open / share this exact local source

Galway University Hospitals - GAPP · Hospitalized adults; Irish institutional guidance, not a US product label.

Renal method: Indexed eGFR, mL/min/1.73 m2; source identifies exceptions requiring Cockcroft-Gault.
Source date: Revision not established in selected retrieval
Retrieved: 2026-09-10

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Before using this finding

Keep route, indication, renal measure and dialysis modality together; do not merge the Galway and UCSF regimens.

Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Renal guidance and important limits

Limits that apply to these rows

The asterisk marks significant differences among references. Usual dosing means the local normal-renal/hepatic regimen.

CRRT is outside this guideline. Route, severity and renal measure must remain attached; do not combine its interval with another source dose.

Galway amoxicillin IV/PO - hospitalized adults
Indexed eGFR (mL/min/1.73 m2)Source-specific instruction
10-50No renal dose adjustment in this institutional table
<10250 mg to 1 g every 8 hours
<10, high-dose endocarditis or Listeria meningitisMaximum 2 g every 8 hours
Read the retained text before reformatting

Galway amoxicillin IV/PO - hospitalized adults

Indexed eGFR (mL/min/1.73 m2)Source-specific instruction
10-50No renal dose adjustment in this institutional table
<10250 mg to 1 g every 8 hours
<10, high-dose endocarditis or Listeria meningitisMaximum 2 g every 8 hours

The asterisk marks significant differences among references. Usual dosing means the local normal-renal/hepatic regimen.

CRRT is outside this guideline. Route, severity and renal measure must remain attached; do not combine its interval with another source dose.

RDM64-professional-amoxicillin-74ab8780ac-C1 · Source locator: General Principles; Assessing Renal Function; amoxicillin row; Renal Replacement Therapy.

Source-specific limits

The asterisk marks significant differences among references. Usual dosing means the local normal-renal/hepatic regimen.

CRRT is outside this guideline. Route, severity and renal measure must remain attached; do not combine its interval with another source dose.

Source identity and provenance
Source family
professional_guidance
Source
https://eguides.megsupporttools.com/public/guh/renal-dosing-adults/?view=menu
Retrieved
2026-09-10
Renal-function method
Indexed eGFR, mL/min/1.73 m2; source identifies exceptions requiring Cockcroft-Gault.
Source date/version
Revision not established in selected retrieval
Hash meaning
Local authored summary, not source HTML/XML/PDF bytes
Local summary SHA-256
7e9e46671be094b08f52aa9f78b1fedd7e4140514cf96d5ae210bbf0383c5d75
Professional

UCSF - amoxicillin oral renal and dialysis tables

Open original reference

Open / share this exact local source

UCSF Infectious Diseases Management Program · Adults; oral dosing for selected indications.

Renal method: CrCl, mL/min; dialysis assumptions stated separately.
Source date: Revision not established in selected retrieval
Retrieved: 2026-09-10

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Before using this finding

Resolve the printed boundary and match the indication, oral route and actual dialysis prescription.

Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Renal guidance and important limits

Limits that apply to these rows

Exactly 30 mL/min is not assigned by the printed >30 / 10-29 headings; seek clarification rather than interpolate.

IHD assumes high-flux HD. Continuous guidance assumes CVVHD at 2 L/hour ultrafiltration with residual GFR <10; limited data/local expert opinion.

UCSF oral amoxicillin - symptomatic Enterococcus UTI
CrCl (mL/min)Source-specific instruction
>30500 mg every 8 hours
10-29500 mg every 12 hours
<10500 mg every 24 hours
UCSF oral amoxicillin - severe infections / selected outpatient CAP
CrCl (mL/min)Source-specific instruction
>301 g every 8 hours
10-291 g every 12 hours
<10500 mg every 12 hours
Dialysis guidance - separate source-specific schedules
UCSF oral amoxicillin dialysis
Setting and indicationSource-specific instruction
Intermittent HD - Enterococcus UTI500 mg once now, then every evening
Continuous HD - Enterococcus UTI500 mg every 8 hours
Intermittent HD - other selected severe infections500 mg every 12 hours
Continuous HD - other selected severe infections1 g every 8 hours
Read the retained text before reformatting

UCSF oral amoxicillin - symptomatic Enterococcus UTI

CrCl (mL/min)Source-specific instruction
>30500 mg every 8 hours
10-29500 mg every 12 hours
<10500 mg every 24 hours

UCSF oral amoxicillin - severe infections / selected outpatient CAP

CrCl (mL/min)Source-specific instruction
>301 g every 8 hours
10-291 g every 12 hours
<10500 mg every 12 hours

UCSF oral amoxicillin dialysis

Setting and indicationSource-specific instruction
Intermittent HD - Enterococcus UTI500 mg once now, then every evening
Continuous HD - Enterococcus UTI500 mg every 8 hours
Intermittent HD - other selected severe infections500 mg every 12 hours
Continuous HD - other selected severe infections1 g every 8 hours

Exactly 30 mL/min is not assigned by the printed >30 / 10-29 headings; seek clarification rather than interpolate.

IHD assumes high-flux HD. Continuous guidance assumes CVVHD at 2 L/hour ultrafiltration with residual GFR <10; limited data/local expert opinion.

RDM64-professional-amoxicillin-9aba957fdf-C1 · Source locator: Adult non-dialysis and intermittent/continuous-HD tables; Dialysis Notes.

Source-specific limits

Exactly 30 mL/min is not assigned by the printed >30 / 10-29 headings; seek clarification rather than interpolate.

IHD assumes high-flux HD. Continuous guidance assumes CVVHD at 2 L/hour ultrafiltration with residual GFR <10; limited data/local expert opinion.

Source identity and provenance
Source family
professional_guidance
Source
https://idmp.ucsf.edu/content/amoxicillin
Retrieved
2026-09-10
Renal-function method
CrCl, mL/min; dialysis assumptions stated separately.
Source date/version
Revision not established in selected retrieval
Hash meaning
Local authored summary, not source HTML/XML/PDF bytes
Local summary SHA-256
8e4dd2297ebc6d34a38e5ab7d6b575789aa78d4f990fe2e1ac67adad24342749

Provenance and preservation

Additional summaries stored on this page: 0 official-label, 1 RX List, 3 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/renal/amoxicillin/
Source retrieval
2026-09-05. This is not the source publication or label revision date.
Original source type
globalrph individual
Local text SHA-256
727e42acd1a74b73ea59a1c9892a8087fe74710a6e00bc4f735ef57464cf4904
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

The original individual GlobalRPh pages commonly cite NIH/NLM DailyMed and instruct readers to review the applicable package insert for updates. That historical reference is preserved as context; it is not counted as an independently retrieved current label.

Read the full coverage report